Report: Two more blood pressure drugs recalled for potential cancer risk
(FOX 46 WJZY) - Teva Pharmaceuticals announced that they've launched a voluntary recall into two drugs used to treat high blood pressure as more medications face concerns over a possible cancer risk.
Teva said in a statement released by the Food and Drug Administration, the recall impacts all lots of combination tablets featuring the drugs amlodipine and valsartan and another combo drug featuring amlodipine, valsartan, and hydrochlorothiazide.
According to the FDA, the drugs could contain an impurity called N-nitroso-diethylamine, which has been classified as a possible human carcinogen.
Those taking either drugs should contact their doctor or pharmacist for advice or alternative treatments. Stopping the drugs immediately with no comparable alternative could pose a greater risk to patients' health, Teva explained.
Lots Under Voluntary Recall:
For the full list of products that are part of this voluntary recall, PLEASE CLICK HERE! Customers and patients with questions can contact Teva by phone at 888-838-2872, or email at druginfo@tevapharm.com.